about
Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases.Mutation in IFT80 in a fetus with the phenotype of Verma-Naumoff provides molecular evidence for Jeune-Verma-Naumoff dysplasia spectrum.Influence of authentic nitric oxide on basal cytosolic [Ca2+] and Ca2+ release from internal stores in human platelets.Prevalence of rare mitochondrial DNA mutations in mitochondrial disordersWDR34 mutations that cause short-rib polydactyly syndrome type III/severe asphyxiating thoracic dysplasia reveal a role for the NF-κB pathway in cilia.Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.Finger creases lend a hand in Kabuki syndrome.[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].First fixed drug eruption due to teicoplanin with a peri-oral distribution.Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.Platelet cytosolic free-calcium concentration is increased in aging and Alzheimer's disease.Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial.Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisicBiochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patientsAcute sodium-dependent changes in membrane dynamic propertiesFurther investigation of platelet cytosolic alkalinization in essential hypertensionEndogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension[Elevation of intraplatelet free Ca2+ in primary hypertension in man and the rat]Regulation of the dynamic properties of platelet plasma membrane by intracellular sodium ionsPlatelet and erythrocyte membrane microviscosity in Lyon hypertensive ratsPlatelet aggregation and in vivo shear forcesPlasma lipids and platelet membrane fluidity in essential hypertensionAcute membrane effects of trimetazidine in human plateletsMembrane microviscosity and plasma triacylglycerols in the ratRelations of platelet Ca2+ handling and membrane microviscosity to vascular tone and restenosis after angioplasty in human coronary arterySuccessful treatment of congenital hyperinsulinism with long-acting release octreotideSafety and accuracy of 64-slice computed tomography coronary angiography in children after the arterial switch operation for transposition of the great arteriesPlatelet cytosolic free calcium concentration in essential hypertension
P50
Q33858868-9FEB5891-918D-4EBA-BB13-CB106F552433Q34610407-BFFC1CF4-DE45-43F7-B18C-581FED73FCACQ35884618-6E0CD6DA-AB72-422F-A657-7AC820C9D544Q37206617-D33409E8-1271-42BE-9AF5-7287FAEEE9FAQ37298127-E6FC9B29-5015-4745-8875-BB5F441431B0Q37633636-DACEDED0-1D95-44AA-A1EF-6A2C54C2BF62Q38414587-A23C2AD7-2470-44AE-AF04-33B68216CE24Q44647682-CC076758-F7B7-4B0A-9734-9DD366DFD206Q44974019-202FDD70-9C18-478E-B024-FCB8FB49165BQ46080748-79E80644-74C0-47E1-BC7F-FC55731AF06BQ50504852-3D75E477-1722-4735-9A76-A50163C8E18EQ51058337-2E99E60C-8F77-436B-87E5-355E72197945Q53085750-D80B9FAA-2144-468A-9BDE-A06C095B769BQ60631397-CA3BBC33-9C72-4B76-9113-5C6F270CAF20Q67492341-CB79A4B3-D9FD-43B5-A75B-10E6D7CDE408Q67776582-78CAD443-D93C-470B-898D-6707B3D4EEC8Q67858678-15E6C3FC-4395-4C26-B865-ECE5C13AACB2Q68469304-3B3E3394-7AE6-424E-86A8-6BD1501EA17EQ69982849-ADE24D02-8D53-43E2-BA46-F22FAAE48946Q70683589-DCD2D152-55F8-45DC-B6DB-18E428DF41F3Q71994028-A3871F62-BBC9-40CA-B141-739CEEC0424FQ72381329-AE01756A-3A39-4424-BF1B-DFDBFA5895C7Q72955403-56ECF185-C5F5-406B-B0AE-DEEC6FE87AB8Q72970873-54922DB7-5E0D-4F00-96D8-DED67BCAE0E4Q74321328-1E255932-AAB7-4960-B4CF-4F74FF28B64BQ74503097-9091ADF2-CCD1-4B9C-AE92-91F63A820645Q82318474-A10CFF3A-6CA2-496D-AF16-0FD1BCAD8334Q83629521-CBB3F181-D35E-4063-A347-C1B8454D018EQ93638262-62738EE6-F906-44D9-A629-FDEF9DACAFB0
P50
description
researcher, ORCID id # 0000-0002-4280-4395
@en
wetenschapper
@nl
name
Kim-Hanh Le Quan Sang
@ast
Kim-Hanh Le Quan Sang
@en
Kim-Hanh Le Quan Sang
@nl
type
label
Kim-Hanh Le Quan Sang
@ast
Kim-Hanh Le Quan Sang
@en
Kim-Hanh Le Quan Sang
@nl
prefLabel
Kim-Hanh Le Quan Sang
@ast
Kim-Hanh Le Quan Sang
@en
Kim-Hanh Le Quan Sang
@nl
P106
P31
P496
0000-0002-4280-4395